http://purl.org/np/RAmU0YHpHOf6gCQB2VjtypjMKJ1VTjQ4mIu-QK1PbYjpw#Head http://purl.org/np/RAmU0YHpHOf6gCQB2VjtypjMKJ1VTjQ4mIu-QK1PbYjpw http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RAmU0YHpHOf6gCQB2VjtypjMKJ1VTjQ4mIu-QK1PbYjpw#assertion http://purl.org/np/RAmU0YHpHOf6gCQB2VjtypjMKJ1VTjQ4mIu-QK1PbYjpw http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RAmU0YHpHOf6gCQB2VjtypjMKJ1VTjQ4mIu-QK1PbYjpw#provenance http://purl.org/np/RAmU0YHpHOf6gCQB2VjtypjMKJ1VTjQ4mIu-QK1PbYjpw http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RAmU0YHpHOf6gCQB2VjtypjMKJ1VTjQ4mIu-QK1PbYjpw#pubinfo http://purl.org/np/RAmU0YHpHOf6gCQB2VjtypjMKJ1VTjQ4mIu-QK1PbYjpw http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RAmU0YHpHOf6gCQB2VjtypjMKJ1VTjQ4mIu-QK1PbYjpw#assertion http://purl.obolibrary.org/obo/DOID_0060224 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RAmU0YHpHOf6gCQB2VjtypjMKJ1VTjQ4mIu-QK1PbYjpw#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_0060224 http://purl.org/np/RAmU0YHpHOf6gCQB2VjtypjMKJ1VTjQ4mIu-QK1PbYjpw#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RAmU0YHpHOf6gCQB2VjtypjMKJ1VTjQ4mIu-QK1PbYjpw#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/drugbank:DB00204 http://purl.org/np/RAmU0YHpHOf6gCQB2VjtypjMKJ1VTjQ4mIu-QK1PbYjpw#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RAmU0YHpHOf6gCQB2VjtypjMKJ1VTjQ4mIu-QK1PbYjpw#association http://www.w3.org/2000/01/rdf-schema#label maintenance of normal sinus rhythm delay in af afl recurrence dofetilide capsules are indicated for the maintenance of normal sinus rhythm delay in time to recurrence of atrial fibrillation atrial flutter af afl in patients with atrial fibrillation atrial flutter of greater than one week duration who have been converted to normal sinus rhythm because dofetilide can cause life threatening ventricular arrhythmias it should be reserved for patients in whom atrial fibrillation atrial flutter is highly symptomatic in general antiarrhythmic therapy for atrial fibrillation atrial flutter aims to prolong the time in normal sinus rhythm recurrence is expected in some patients see clinical studies conversion of atrial fibrillation flutter dofetilide capsules are indicated for the conversion of atrial fibrillation and atrial flutter to normal sinus rhythm dofetilide capsules have not been shown to be effective in patients with paroxysmal atrial fibrillation http://purl.org/np/RAmU0YHpHOf6gCQB2VjtypjMKJ1VTjQ4mIu-QK1PbYjpw#association https://w3id.org/biolink/vocab/association_type https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation http://purl.org/np/RAmU0YHpHOf6gCQB2VjtypjMKJ1VTjQ4mIu-QK1PbYjpw#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RAmU0YHpHOf6gCQB2VjtypjMKJ1VTjQ4mIu-QK1PbYjpw#association https://w3id.org/biolink/vocab/relation https://schema.org/TreatmentIndication https://identifiers.org/drugbank:DB00204 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RAmU0YHpHOf6gCQB2VjtypjMKJ1VTjQ4mIu-QK1PbYjpw#provenance http://purl.org/np/RAmU0YHpHOf6gCQB2VjtypjMKJ1VTjQ4mIu-QK1PbYjpw#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAmU0YHpHOf6gCQB2VjtypjMKJ1VTjQ4mIu-QK1PbYjpw#pubinfo http://purl.org/np/RAmU0YHpHOf6gCQB2VjtypjMKJ1VTjQ4mIu-QK1PbYjpw#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RAmU0YHpHOf6gCQB2VjtypjMKJ1VTjQ4mIu-QK1PbYjpw#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RAmU0YHpHOf6gCQB2VjtypjMKJ1VTjQ4mIu-QK1PbYjpw#sig http://purl.org/nanopub/x/hasSignature d/XvXs8aGarSto2UdBRoUBqJqrXg7i59hDSk3XB+cznXNPntvJjdFHo1XTogQkNCaTMLiQq98rTY/+nQONxOUhvwt1mJeyTp3cGa2Vcwf+v9fg5tTX5Dz0M0Cjrz7aRwVKi+uZMAMUS1h3RiPaUL2KkDnem3GaQ72b5pTPLpyF0= http://purl.org/np/RAmU0YHpHOf6gCQB2VjtypjMKJ1VTjQ4mIu-QK1PbYjpw#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RAmU0YHpHOf6gCQB2VjtypjMKJ1VTjQ4mIu-QK1PbYjpw http://purl.org/np/RAmU0YHpHOf6gCQB2VjtypjMKJ1VTjQ4mIu-QK1PbYjpw http://purl.org/dc/terms/created 2021-06-27T20:12:56.866+02:00 http://purl.org/np/RAmU0YHpHOf6gCQB2VjtypjMKJ1VTjQ4mIu-QK1PbYjpw http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAmU0YHpHOf6gCQB2VjtypjMKJ1VTjQ4mIu-QK1PbYjpw https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RAmU0YHpHOf6gCQB2VjtypjMKJ1VTjQ4mIu-QK1PbYjpw https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RAmU0YHpHOf6gCQB2VjtypjMKJ1VTjQ4mIu-QK1PbYjpw https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs